Δημοσίευση στις 2017/9/28 στο PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28951194
Ultrafiltration stands as an alternate treatment option for patients with acute or chronic advanced heart failure and associated kidney injury. The optimal access site for this therapy needs careful patient evaluation and communication, and this is especially important for chronic treatment plans. A new prospective study published in the journal provides insight on the optimal access site and offers directions for future research.
Copyright © 2017 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.